Prednisolone Oral Solution Recalled Due to Manufacturing Standards Deviation
Akorn, Inc. is recalling all lots of Prednisolone Oral Solution 15 mg/5 mL due to a manufacturing standards deviation. The company discontinued required stability studies after ceasing operations.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II recall with no reported illnesses or injuries. The hazard is a CGMP deviation involving incomplete stability studies, which represents a theoretical risk of product degradation rather than a documented safety incident. Per the rubric, recalls without reported illness and with theoretical hazards score at most 3.
Plain-English summary
Akorn, Inc. is recalling all lots of Prednisolone Oral Solution, USP, 15 mg/5 mL, packaged in 240 mL and 480 mL bottles distributed nationwide in the USA and Puerto Rico.
The recall was initiated due to a Current Good Manufacturing Practice (CGMP) deviation. Akorn went out of business and ceased conducting the required ongoing stability studies for this medication.
Stability studies are conducted to ensure a pharmaceutical product remains safe and effective throughout its labeled shelf life. The discontinuation of these studies means the company could no longer demonstrate that the product would maintain its integrity and potency.
The recalled product
- Product
- Prednisolone Oral Solution, USP, 15 mg/5 mL, packaged in a) 240 mL and b) 480 mL bottles, Rx Only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs
- Manufacturer
- Akorn, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Part of a larger recall action
This product is one of 86 recalled by Akorn, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 86 products in this recall →Related recalls
Same manufacturer · Akorn, Inc.
See all →- HighTobramycin Ophthalmic Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighGuaifenesin Oral Solution Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Calcitriol Injection Due to Manufacturing Practice Violations
FDA (Drugs) · 2023-06-07
- HighAkorn Hydromorphone Hydrochloride Injection Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07
- HighMidazolam Injection Recalled Due to Manufacturing Compliance and Stability Study Issues
FDA (Drugs) · 2023-06-07
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- HighPrednisoLONE Oral Solution Recalled for Defective Container Seals
FDA (Drugs) · 2022-08-24
- LowTeva Recalls Prednisolone Oral Solution for Failed Stability Specifications
FDA (Drugs) · 2017-05-17
- LowAkorn Recalls Nystatin Oral Suspension Due to Unknown Impurity
FDA (Drugs) · 2019-04-10
- LowAkorn Recalls Prednisolone Sodium Phosphate Oral Solution Due to Discoloration
FDA (Drugs) · 2020-06-17
- HighProparacaine Ophthalmic Solution Recalled for Manufacturing Quality Deviations
FDA (Drugs) · 2023-01-25
- ModerateAkorn Recalls Gabapentin Oral Solution Due to Impurity Specifications
FDA (Drugs) · 2021-03-24